☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Alvogen Signs an Exclusive Commercialization Agreement with Three Pharma Companies for PF708 (biosimilar- teriparatide)
October 23, 2019
Novo Nordisk's Fiasp (insulin aspart injection) Receives the FDA's Approval for use in Insulin Infusion Pumps to Treat Type 1 or T...
October 23, 2019
Biogen and Eisai Plan to File BLA to the US FDA for Aducanumab to Treat Alzheimer's Disease
October 23, 2019
BerGenBio's Bemcentinib Receives the US FDA's Fast Track Designation for Relapsed Acute Myeloid Leukemia
October 23, 2019
Brii Biosciences Collaborates with Qpex to Develop and Commercialize Antibiotics for Drug-Resistant Infections in China
October 23, 2019
Biomica Signs an Agreement with Weizmann Institute of Science to Develop a Selective Treatment Against Antibiotic-Resistant Bacter...
October 23, 2019
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions